Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

< Back to Article

Table 1.

Characteristics and prevalence of multimorbidity and polypharmacy in CLSA and CPCSSN.

More »

Table 1 Expand

Table 2.

Prevalence and patterns of multimorbidity and polypharmacy in CLSA participants aged 45 to 64 years, overall and stratified by sex.

More »

Table 2 Expand

Table 3.

Prevalence and patterns of multimorbidity and polypharmacy in CPCSSN patients aged 45 to 64 years, overall and stratified by sex.

More »

Table 3 Expand

Table 4.

Prevalence and patterns of multimorbidity and polypharmacy in CLSA participants aged 65 to 85 years, overall and stratified by sex.

More »

Table 4 Expand

Table 5.

Prevalence and patterns of multimorbidity and polypharmacy in CPCSSN patients aged 65 to 85 years, overall and stratified by sex.

More »

Table 5 Expand

Fig 1.

Prevalence of multimorbidity (two or more conditions) and polypharmacy (five or more medications) in CLSA and CPCSSN cohorts, stratified by age group and sex.

More »

Fig 1 Expand

Fig 2.

Prevalence of multimorbidity (three or more conditions) and polypharmacy (five or more medications) in CLSA and CPCSSN cohorts, stratified by age group and sex.

More »

Fig 2 Expand